Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cybin Inc (CLXPF)

Cybin Inc (CLXPF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 453,224
  • Shares Outstanding, K 148,598
  • Annual Sales, $ 650 K
  • Annual Income, $ -24,420 K
  • 60-Month Beta N/A
  • Price/Sales 603.54
  • Price/Cash Flow N/A
  • Price/Book 6.23
Trade CLXPF with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.14
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.05
  • Number of Estimates 3
  • High Estimate -0.03
  • Low Estimate -0.06
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.01%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.1105 +44.99%
on 07/08/21
3.3800 -9.47%
on 08/02/21
+0.9400 (+44.34%)
since 07/02/21
3-Month
1.3429 +127.87%
on 06/01/21
3.3800 -9.47%
on 08/02/21
+1.3050 (+74.36%)
since 05/03/21

Most Recent Stories

More News
Cybin Announces Closing of Overnight Marketed Public Offering of Common Shares and Exercise of Over-Allotment Option

Cybin Inc. (NEO:CYBN) (OTCQB: CLXPF) ("Cybin" or the "Company"), a biotechnology company focused on progressing psychedelic therapeutics, is pleased to announce that it has closed its previously announced...

CLXPF : 3.0600 (-3.77%)
Cybin Receives Final Approval to Commence Trading on the NYSE American on or About August 5

Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) ("Cybin" or the "Company"), a biotechnology company focused on progressing psychedelic therapeutics, today announced that it has received approval for the listing of...

CLXPF : 3.0600 (-3.77%)
Cybin Announces Size and Pricing of Previously Announced Overnight Marketed Public Offering of Common Shares

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) ("Cybin" or the "Company"), a biotechnology company focused on progressing psychedelic therapeutics, announced today the pricing of its previously announced overnight...

CLXPF : 3.0600 (-3.77%)
Psilocybin May Be the Key to Resolving the Global Obesity Epidemic

The global obesity issue is bursting at the seams. According to the World Health Organization, obesity ...

CLXPF : 3.0600 (-3.77%)
MMEDF : 4.6900 (+33.24%)
CMPS : 33.07 (-2.56%)
NMDBF : 0.1242 (+3.59%)
TRYP.CN : 0.610 (unch)
NEON.CN : 0.155 (+6.90%)
Cybin Announces Overnight Marketed Public Offering of Common Shares

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) ("Cybin" or the "Company"), a biotechnology company focused on progressing psychedelic therapeutics, is pleased to announce that it has launched an overnight marketed...

CLXPF : 3.0600 (-3.77%)
Psychedelics -- Not Just for Mental Health Anymore

/PRNewswire/ -- In , Congress created what is known as Breakthrough Therapy designation, a distinction that affords biotechnology and pharmaceutical companies an expedited review process for experimental...

ATAI : 14.97 (-4.28%)
TRYP.CN : 0.610 (unch)
TRYPF : 0.4800 (-9.43%)
CMPS : 33.07 (-2.56%)
MNMD : 3.00 (-2.28%)
CLXPF : 3.0600 (-3.77%)
Cybin Announces Conditional Listing Approval from NYSE American

Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) ("Cybin" or the "Company"), a biotechnology company focused on progressing psychedelic therapeutics, today announced that it has received conditional listing approval...

CLXPF : 3.0600 (-3.77%)
Cybin Files its 13th Patent Application and Announces Digital Therapeutics Strategy

Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) ("Cybin" or the "Company"), a biotechnology company focused on progressing psychedelic therapeutics, today announced that it has filed its 13th new provisional patent...

CLXPF : 3.0600 (-3.77%)
Cybin to Participate in Cowen's Psychedelics & Novel Mechanisms in Neuropsychiatry Virtual Summit on July 13th

Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) ("Cybin" or the "Company"), a biotechnology company focused on progressing psychedelic therapeutics, today announced that Doug Drysdale, Chief Executive Officer, will...

CLXPF : 3.0600 (-3.77%)
Cybin Expands to Europe and Provides Update on Intellectual Property Portfolio

Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) ("Cybin" or the "Company"), a biotechnology company focused on progressing psychedelic therapeutics, today announced the scaling up of its European operations and research...

CLXPF : 3.0600 (-3.77%)

Key Turning Points

3rd Resistance Point 3.5750
2nd Resistance Point 3.4000
1st Resistance Point 3.2300
Last Price 3.0600
1st Support Level 2.8850
2nd Support Level 2.7100
3rd Support Level 2.5400

See More

52-Week High 3.3800
Last Price 3.0600
Fibonacci 61.8% 2.2775
Fibonacci 50% 1.9369
Fibonacci 38.2% 1.5963
52-Week Low 0.4938

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar